LFG
CRMD icon

Larson Financial Group’s CorMedix CRMD Stock Holding History

Larson Financial Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96K Buy
249
+96
+63% +$758 ﹤0.01% 3124
2026
Q1 		$1.04K Sell
153
-42
-22% -$310 ﹤0.01% 3144
2025
Q4 		$2.27K Sell
195
-313
-62% -$3.46K ﹤0.01% 2745
2025
Q3 		$5.91K Buy
+508
New +$6.14K ﹤0.01% 2289

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Larson Financial Group's CRMD Position: Q2 2026 in Review

Larson Financial Group increased its CorMedix (CRMD) stake by 63% in Q2 2026, buying an estimated $758 and bringing the position to 249 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3124.

Larson Financial Group first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.91K in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Larson Financial Group held 249 shares of CorMedix worth $1.96K as of Q2 2026.
  • Larson Financial Group bought 96 CorMedix shares in Q2 2026, an estimated $758.
  • CorMedix made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3124 holding.
  • Larson Financial Group first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • Larson Financial Group's CorMedix position peaked at $5.91K in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.